European Archives - Page 229 of 1216 - European Medical Journal

Whole-Body MRI in Oncology

Whole-body magnetic resonance imaging (WB-MRI) has significantly improved oncological disease management by enabling comprehensive…

Atopic Dermatitis as a Risk Factor for Inflammatory Bowel Disease

Shared genetic, environmental, and microbial factors suggest a potential relationship between these diseases.

Alpha Blockers Linked to Fracture Risk in Female Patients With Chronic Kidney Disease

Alpha blockers increase fracture risk in female CKD patients treated for voiding dysfunction, emphasising the need for cautious prescribing.

Gold crown on blue background

Could Eli Lilly take the crown in the obesity market?

According to a recent release from GlobalData, Eli Lilly’s obesity offering could become a potential leader in the market.

African American Men Respond Better to Ra-223 Treatment

African American men with mCRPC may experience better outcomes than white men when treated with radium-223 dichloride.

Human versus Machine: Navigating Clinical Safety

In this episode, Jonathan Sackier sits down with Tom Bradshaw to explore the rapidly evolving landscape of digital health. They discuss Bradshaw’s expertise in the clinical application of AI and digital technologies, his work with the NHS and private sector firms, and more.

Cutting Blood Loss: Hypovolaemic Phlebotomy in Liver Surgery

The study’s findings demonstrate that hypovolaemic phlebotomy effectively reduces the need for red blood cell transfusions.

Improving Gestational Diabetes Diagnosis Through Enhanced Glucose Processing

Enhanced glucose processing during oral glucose tolerance testing significantly improves the accuracy and equity of gestational diabetes diagnosis.

New Metric Offers Insight into Red Blood Cell Function and Quality

A recent study has introduced FlowScore, a new metric for evaluating the quality of red blood cells that goes beyond traditional haemoglobin assays…

Avacopan Therapy Linked to Liver Injury in Patients With Vasculitis

Avacopan therapy for vasculitis carries a risk of liver injury, particularly in elderly and low-weight patients, highlighting the need for regular monitoring.